Sponsor pipeline

MSD R&D (China) Co., Ltd. clinical trial pipeline

Get alerts when MSD R&D (China) Co., Ltd.'s trials change

2 active trials 2 recruiting 3 disease areas 2 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

What changed in the last 30 days

2026-08-21
Primary completion pushed: 2028-06-30 → 2028-12-31
Completion pushed: 2028-06-30 → 2028-12-31
NCT05579132 A Clinical Study of MK-1045 (CN201) in People With Precursor B-cell Acute Lymphoblastic… · Phase 1/2

Active trials by phase

Phase 1
1
Phase 1/2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT05579132 A Clinical Study of MK-1045 (CN201) in People With Precursor B-cell Acute Lymphoblastic… Acute Lymphoblastic Leukemia Recruiting 2026-08-20
Phase 1
NCT06189391 A Study to Evaluate MK-1045 (CN201) in Participants With Relapsed or Refractory B-Cell… Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma Recruiting 2026-06-26

Disease areas by active trials

Leukemia (1) · Acute Lymphoblastic Leukemia (ALL) (1) · Non-Hodgkin Lymphoma (1)

Get alerts when MSD R&D (China) Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free